Related Experiment Videos
Serotonergic platelet markers of suicidal behavior--do they really exist?
B Müller-Oerlinghausen1, J Roggenbach, L Franke
1Former Research Group Clinical Psychopharmacology, Freie Universität Berlin, 14050 Berlin, Germany. bmoe@zedat.fu-berlin.de
Journal of Affective Disorders
|March 17, 2004
Summary
Platelet serotonin transporter, receptor, and MAO-B activity studies show inconsistent results regarding suicidality. Methodological flaws, including small sample sizes and inadequate controls, limit the validity of current findings and prevent a cohesive biological model.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Platelets are investigated as peripheral markers for central serotonergic functions.
- Previous research suggests a link between platelet abnormalities and suicidality/depression, but findings are inconsistent.
Purpose of the Study:
- To review and analyze contradictory findings on platelet markers and suicidality.
- To identify potential methodological flaws contributing to discrepancies in research.
Main Methods:
- Review of selected, frequently cited publications.
- Analysis of studies examining platelet 5-HT transporter, imipramine binding sites, serotonin content, 5-HT(2) receptor binding, and MAO-B activity.
Main Results:
- Inconsistent associations between platelet 5-HT transporter and suicidality.
- Low specificity of imipramine for the 5-HT transporter.
- Potential confounding factors for platelet serotonin content (washout periods, blood loss).
- Methodological issues in studies of platelet 5-HT(2) receptors and MAO-B activity.
Conclusions:
- Methodological limitations (sample size, controls, ligands, comorbidity) hinder study validity and comparability.
- Current findings cannot be integrated into a plausible biological model of suicidality.